Skip To Main Content
Supanut Apinyawasisuk on Muck Rack

Supanut Apinyawasisuk

As seen in: Nature, PLOS ONE
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Supanut

Contact Supanut, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Phase 1 dose-finding study of topical neostigmine ophthalmic solution for alleviating myasthenic ptosis

|
By Supanut Apinyawasisuk, Supharat Jariyakosol, Pajaree Chariyavilaskul, Kornvalee Meesilpavikkai, Yuda Chongpison, Chuthamas Ongprakobkul
| Nature Verified
Abstract The study aimed to investigate the safety, optimal biologic dose, and preliminary efficacy of topical neostigmine ophthalmic solution (TNOS) in myasthenia gravis (MG) patients with ptosis. A dose-escalation study comprising cohorts of three patients in each step was performed. The first cohort received 1.5 mg/mL TNOS and was evaluated for safety and efficacy.
Open in Who Shared Issue with article?

Health-related quality of life of daily-life-affected benign essential blepharospasm: Multi-center observational study

|
By Parima Hirunwiwatkul, Wajamon Supawatjariyakul, Supharat Jariyakosol, Supanut Apinyawasisuk
| paperity.org
PLOS ONE, Mar 2023 This is a preview of a remote PDF: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0283111&type=printable Parima Hirunwiwatkul, Wajamon Supawatjariyakul, Supharat Jariyakosol, Supanut Apinyawasisuk, Jiruth Sriratanaban, Yuda Chongpison, Priya Jagota, Nipat Aui-aree, Juthamat Witthayaweerasak, Suwanna Setthawatcharawanich, Kitthisak Kitthaweesin, Niphon Chirapapaisan, Piyawadee Chaimongkoltrakul, Poramaet Laowanapiban, Linda Hansapinyo, Suthida...
Open in Who Shared Issue with article?

Health-related quality of life of daily-life-affected benign essential blepharospasm: Multi-center observational study

|
By Parima Hirunwiwatkul, Wajamon Supawatjariyakul, Supharat Jariyakosol, Supanut Apinyawasisuk
| PLOS ONE
Loading metrics Open Access Peer-reviewed Research Article Abstract Purpose To compare Thais’ health-related quality of life (HRQOL) and severity grading, efficacy and safety in daily-life-affected benign essential blepharospasm (BEB) patients at baseline and after Botulinum toxin type A (BTX-A) treatment. Design Prospective-observational study.
Open in Who Shared Issue with article?
See all 3 articles